MYnd Analytics and Emmaus Life Sciences Report Progress on Merger and Spin-off TransactionJuly 09, 2019
Merger and Spin-off Transaction on Track to Close by End of July New Spin-Off Record Date Set for July 15, 2019
Read More
Merger and Spin-off Transaction on Track to Close by End of July New Spin-Off Record Date Set for July 15, 2019
Read MoreStudy will evaluate change in number and size of colonic diverticula and assess safety.
Read MoreEmmaus Life Sciences, Inc., a leader in sickle cell disease treatment, announced today the hiring of Michael Schwarz as its new Product Manager for Endari®
Read MoreEmmaus to use its pharmaceutical-grade L-glutamine ("PGLG") in a clinical study to determine its efficacy in lowering blood sugar in patients with type II diabetes.
Read More